SpringWorks secures FDA approval of Ogsiveo to treat desmoid tumours
The FDA approval is based on positive data from the Phase 3 DeFi trial, in which Ogsiveo significantly…
Arcturus secures FDA orphan drug designation for ARCT-032 in cystic fibrosis
28 Nov 23ARCT-032 has been designed to use the firm’s LUNAR lipid-mediated aerosolised platform to provide CFTR messenger RNA to…
Regeneron, Sanofi’s Dupixent reduces COPD exacerbations in second Phase 3 trial
28 Nov 23In the trial, Dupixent reduced moderate or severe acute COPD exacerbations by 34% over 52 weeks and led…
GSK’s Blenrep meets primary endpoint in Phase 3 multiple myeloma trial
28 Nov 23The drug achieved the primary endpoint of progression-free survival and extended the time to disease progression or death…
Boehringer Ingelheim, IBM partner to expedite antibody discovery
28 Nov 23Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
Certest completes the expansion of its new facilities
28 Nov 23The construction of the two new buildings has represented an investment of 22 million euros
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
28 Nov 23DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford…
deepc Establishes MONAI Compatibility, Strengthening Its Commitment to Open-Source Collaboration and Global Healthcare Transformation
28 Nov 23deepc, a leading MedTech company, aligns strategically with MONAI, the Medical Open Network for Artificial Intelligence. A community-driven…
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
28 Nov 23Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities
Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders
28 Nov 23New clinical data from Octapharma's haematology portfolio will be presented during the scientific program at the 65th American…